Navigation Links
TAXUS OLYMPIA Registry Shows Excellent Outcomes for High-Risk Patients Treated With Second-Generation TAXUS(R) Liberte(R) Stent
Date:9/2/2008

NATICK, Mass. and Munich, Germany, Sept. 2 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX) today announced positive one-year results from the European and Intercontinental launch phases of its global TAXUS OLYMPIA registry, the world's largest post-approval, prospective registry for a single drug-eluting stent (DES). OLYMPIA is designed to analyze real-world clinical outcomes data for Boston Scientific's second-generation TAXUS(R) Liberte(R) Paclitaxel-Eluting Coronary Stent System in the treatment of patients with coronary artery disease. Results from the 22,000-patient study were presented by Oscar Mendiz, M.D., at the European Society of Cardiology Congress in Munich, Germany.

The TAXUS OLYMPIA registry employs a consecutive enrollment process and consists of diverse and high-risk patient populations, reflecting real-world usage patterns found in everyday clinical practice. One-year data were collected for a total of 22,345 patients to date in 57 countries. A large majority of patients (75%) were considered "expanded use" cases consisting of complex lesions or complex clinical characteristics. The overall OLYMPIA population in these two phases included patients with multivessel disease (56.5%), prior PCI (27.9%), prior myocardial infarction (MI) (34.1%), multiple stents (32.3%), and medically treated diabetes (27.0%).

The one-year results demonstrated a low overall 3.8 percent rate of TAXUS Liberte stent-related composite cardiac events, including cardiac death (1.2%), MI (0.8%), and re-intervention (TLR) (2.5%). The definite stent thrombosis rate was 0.8 percent after one year, which is consistent with safety data from other DES registries. In the more complex expanded use patient population, the rates
'/>"/>

SOURCE Boston Scientific Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. SPIRIT III Results Reaffirm Strong Performance of Boston Scientific PROMUS(TM) and TAXUS(R) Express(R) Stents
2. TAXUS(R) Stent Demonstrates Similar Outcomes in Diabetic Patients Compared to Non-diabetics in Pooled Analysis of TAXUS IV and V Trials
3. Study Finds Taxus(R) Drug-Eluting Stent Beneficial in Treatment of Large Vessels
4. TAXUS(R) Express(TM) Stent Shows Similarly Low Re-intervention Rates in Diabetic Patients Compared to Non-Diabetics in ARRIVE 1 and 2 registries
5. OrbusNeichs Genous(TM) Bio-engineered R Stent(TM) has Lower MACE Rate than TAXUS(R) and CYPHER(R) Stents in Clinical Trial
6. Positive Five-Year Safety Data for TAXUS(R) Stent Reported in Boston Scientific Trial
7. Abbotts XIENCE(TM) V Everolimus Eluting Coronary Stent Shows Continued Superiority to TAXUS Stent in Reducing Major Adverse Cardiac Events in SPIRIT III Clinical Trial
8. Boston Scientific PROMUS(TM) and TAXUS(R) Stents Continue Strong Performance in Safety and Efficacy Measures
9. Preliminary Results of Randomized Pilot Study Show Comparable Efficacy for OrbusNeichs Genous(TM) Bio-engineered R Stent(TM) and Boston Scientifics Taxus(R) Stent in Patients at High Risk of Restenosis
10. Boston Scientific to Release Broad Range of Clinical Trial Data Reinforcing Safety and Efficacy of Taxus(R) Coronary Stent Systems at TCT 2007
11. TAXUS WOMAN Study Reports Positive Clinical Outcomes for the TAXUS(R) Drug-eluting Stent in Women
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... Coordinators, Inc. (PCI) is pleased to announce it has ... Limited (Penn Pharma). Penn Pharma is headquartered in Tredegar, ... Kingdom and operates regional offices in ... Tokyo , Japan. Penn Pharma offers both drug development ... manufacturing, as well as Clinical Packaging, Labeling, and global ...
(Date:7/30/2014)... FOREST, Ill., July 30, 2014  Hospira, Inc. ... provider of injectable drugs and infusion technologies, today ... 30, 2014. Net sales for the quarter were ... were $0.72. (Adjusted* measures exclude specified items as ... attached schedules.) On a U.S. Generally Accepted Accounting ...
(Date:7/30/2014)... VILLAGE, Nev. , July 30, 2014  PDL ... announced that company management will participate in the Jefferies ... Boston , Massachusetts. The conference will occur on August ... About PDL BioPharma, Inc. PDL BioPharma manages ... of its Queen et al. antibody humanization patents and ...
Breaking Medicine Technology:PCI Announces Definitive Agreement to Acquire Penn Pharma 2PCI Announces Definitive Agreement to Acquire Penn Pharma 3PCI Announces Definitive Agreement to Acquire Penn Pharma 4PCI Announces Definitive Agreement to Acquire Penn Pharma 5Hospira Reports Second-Quarter 2014 Results 2Hospira Reports Second-Quarter 2014 Results 3Hospira Reports Second-Quarter 2014 Results 4Hospira Reports Second-Quarter 2014 Results 5Hospira Reports Second-Quarter 2014 Results 6Hospira Reports Second-Quarter 2014 Results 7Hospira Reports Second-Quarter 2014 Results 8Hospira Reports Second-Quarter 2014 Results 9Hospira Reports Second-Quarter 2014 Results 10Hospira Reports Second-Quarter 2014 Results 11Hospira Reports Second-Quarter 2014 Results 12Hospira Reports Second-Quarter 2014 Results 13Hospira Reports Second-Quarter 2014 Results 14Hospira Reports Second-Quarter 2014 Results 15Hospira Reports Second-Quarter 2014 Results 16Hospira Reports Second-Quarter 2014 Results 17Hospira Reports Second-Quarter 2014 Results 18Hospira Reports Second-Quarter 2014 Results 19Hospira Reports Second-Quarter 2014 Results 20Hospira Reports Second-Quarter 2014 Results 21Hospira Reports Second-Quarter 2014 Results 22Hospira Reports Second-Quarter 2014 Results 23Hospira Reports Second-Quarter 2014 Results 24Hospira Reports Second-Quarter 2014 Results 25Hospira Reports Second-Quarter 2014 Results 26Hospira Reports Second-Quarter 2014 Results 27Hospira Reports Second-Quarter 2014 Results 28Hospira Reports Second-Quarter 2014 Results 29Hospira Reports Second-Quarter 2014 Results 30Hospira Reports Second-Quarter 2014 Results 31PDL BioPharma to Participate in Jefferies 2014 Boston Healthcare Summit 2
... Surgical Company (Nasdaq: STAA ), a leading ... today announced that it expects revenue for the fourth ... Revenues for the full year were approximately $55 million, ... increase of approximately 10% in revenues from the core ...
... Nalco (NYSE: NLC ), providing essential ... Water and Process Services division is implementing a price ... or as contracts permit.  Pricing for most Nalco programs ... product mix. Price increases will vary by country and ...
Cached Medicine Technology:STAAR Surgical Announces Fourth Quarter 2010 Revenue Expected to Exceed $14.2 Million 2STAAR Surgical Announces Fourth Quarter 2010 Revenue Expected to Exceed $14.2 Million 3STAAR Surgical Announces Fourth Quarter 2010 Revenue Expected to Exceed $14.2 Million 4Nalco Announces Price Increase 2Nalco Announces Price Increase 3
(Date:7/30/2014)... elderly American adults is being financially exploited often ... crisis especially affects poor and black people. It merits ... citizen who cares about the dignity and well-being of ... Medical College in the US. She led one of ... findings of which appear in the Journal of ...
(Date:7/30/2014)... hospital in Ireland has shown than many of them did ... the risk of entrapment. The report, published online in the ... for careful selection of patients for whom bedrails are to ... maintenance of hospital bed systems. , Bedrails are commonly used ... although the risk for any individual is extremely low, people ...
(Date:7/30/2014)... The report entitled “Global Pulse Oximetry Market: Trends ... dynamics and changing trends in the global pulse oximetry ... sizing of the global pulse oximetry market and also ... same. It further captures the global market share based ... Further, the report discusses the domestic market of United ...
(Date:7/30/2014)... Los Angeles cosmetic dentist , ... that can help patients create their dream smiles at ... gums form the foundation of smile confidence, but cosmetic ... misshapen teeth or stains may not interfere with dental ... The right cosmetic treatments can eliminate chips, erase stains ...
(Date:7/30/2014)... July 30, 2014 Building ENT and ... allergy, and audiology practice in Westchester County takes the ... technology, a superb underlying corporate structure and protocols, and ... also takes a leading Chief Financial Officer to help ... (WCBJ), that’s exactly what it possesses. In fact, in ...
Breaking Medicine News(10 mins):Health News:Older adults are at risk of financial abuse 2Health News:High frequency of potential entrapment gaps in hospital beds 2Health News:Global Pulse Oximetry Market 2018 Opportunities and Trends Now Available at MarketReportsOnline.com 2Health News:Global Pulse Oximetry Market 2018 Opportunities and Trends Now Available at MarketReportsOnline.com 3Health News:Los Angeles Cosmetic Dentist, Dr. Poneh Ghasri, Now Offers Comprehensive Cosmetic Dental Treatments 2Health News:Los Angeles Cosmetic Dentist, Dr. Poneh Ghasri, Now Offers Comprehensive Cosmetic Dental Treatments 3Health News:The Leading Ear, Nose, and Throat Practice in Westchester County Has One of the Leading CFO’s in Westchester County! 2Health News:The Leading Ear, Nose, and Throat Practice in Westchester County Has One of the Leading CFO’s in Westchester County! 3
... IRVINE, Calif. , March 11 Renowned pediatrician, author, and lecturer Dr. William Sears ... of children,s supplements and healthy snacks at the Natural Products Expo West convention to be held in ... help nourish young bodies and minds." , ... ...
... ... security has wide-ranging benefits compared to its costs in the fight against poverty-related problems, ... on global hunger. He cites findings from Nobel laureates and a Lancet medical journal ... ...
... ... CareLogic™ user community. , ... Nashville, Tenn. (Vocus) March 11, 2010 -- Qualifacts Systems Inc. , the ... management systems to behavioral health and human services providers, has added New Directions Inc. ...
... ... President of International Orion Health – Charles Scatchard. Orion Health celebrates “phenomenal success” with ... , ... (PRWEB) March 12, 2010 -- To further the ongoing success with implementing Healthcare IT ...
... for Tap Water at Participating Restaurants or Via Tapproject.org During World Water Week ( March 21-27, 2010 ) , ... , , ... ... as Campaign Spokesperson , ...
... than smoking pot, snorting cocaine among 12-year-olds, study finds ... have used inhalants to get high than marijuana, ... , These potentially deadly inhalants include aerosol computer cleaners, ... or sniffed and can cause addiction or sudden death ...
Cached Medicine News:Health News:America's Pediatrician Dr. Bill Sears Answers Michelle Obama's Call to Action to Help Eradicate Obesity 2Health News:America's Pediatrician Dr. Bill Sears Answers Michelle Obama's Call to Action to Help Eradicate Obesity 3Health News:Nutritional Aid is Cost-effective Measure Against Health and Hunger Problems, World Vision Tells Congress 2Health News:Nutritional Aid is Cost-effective Measure Against Health and Hunger Problems, World Vision Tells Congress 3Health News:Qualifacts is Behavioral Health SaaS Provider of Choice in Connecticut 2Health News:Orion Health Showcases Industry Leading EHR Software at WoHIT 2Health News:Orion Health Showcases Industry Leading EHR Software at WoHIT 3Health News:Orion Health Showcases Industry Leading EHR Software at WoHIT 4Health News:Orion Health Showcases Industry Leading EHR Software at WoHIT 5Health News:2010 UNICEF Tap Project Launches to Help Provide Safe Water to Children Worldwide 2Health News:2010 UNICEF Tap Project Launches to Help Provide Safe Water to Children Worldwide 3Health News:2010 UNICEF Tap Project Launches to Help Provide Safe Water to Children Worldwide 4Health News:2010 UNICEF Tap Project Launches to Help Provide Safe Water to Children Worldwide 5Health News:2010 UNICEF Tap Project Launches to Help Provide Safe Water to Children Worldwide 6Health News:Inhalant Abuse a Deadly Middle-School Concern 2
... bench style refrigerator (can be situated on or ... of bags is to be stored as in ... white colorbond steel while the interior is a ... door is key lockable. Control panel is flush ...
The Testosterone Enzyme Immunoassay is intended for the quantitative determination of Testosterone concentration in human serum. No special pretreatment of the sample is necessary. For in vitro Diag...
DSL-10-49300 is a rapid, direct enzyme immunoassay (EIA) kit that provides materials for the quantitative measurement of testosterone in saliva. This assay requires no sample extraction or pretreat...
... This HPLC for Vitamin B6 makes ... an easy, fast and precise method. The ... form for preparation and separation of the ... of HPLC analytics is the simultaneous handling ...
Medicine Products: